Lopinavir/ritonavir long-term therapy good value for treatment-naive patients

By  

Inpharma, Vol. 1, Iss. 1367, 2002-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Long-term lopinavir/ritonavir effective in HIV infection

By  

Inpharma, Vol. 1, Iss. 1435, 2004-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Lopinavir/Ritonavir Compared with Atazanavir in Antiretroviral-Naive Patients: Modelling the Combined Effects of HIV and Heart Disease

By Simpson Kit N.  

Clinical Drug Investigation, Vol. 27, Iss. 1, 2007-01 ,pp. : 67-74

Adis International

Access to resources Recommend Favorite

Meta-analysis of once-daily and twice-daily lopinavir/ritonavir combined with NRTIs in HIV-1-infected, antiretroviral-naive patients

By van Wyk Jean   Qaqish Roula   Hollar Kimberly   White Kelly   D’’Amico Ronald   Norton Michael   Chiu Yi-Lin   King Martin  

Future Virology, Vol. 7, Iss. 1, 2012-01 ,pp. : 103-113

Future Medicine

Access to resources Recommend Favorite

Lopinavir/ritonavir of value across Europe for HIV

By  

Inpharma, Vol. 1, Iss. 1619, 2008-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite